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Introduction
• Metastasis is a serious threat to cancer patients, as it
is one of the major causes of all cancer deaths.
• Genetic screening in mice and subsequent testing
has identified Med4, a subunit of the Mediator
complex, as a dormancy enforcer, or repressor of
metastatic reactivation. The Mediator complex is a
multiprotein coactivator that regulates RNA
polymerase II-related transcription.
• Interestingly, cancer patient dataset analyses
indicate that lower levels of Med4 correlate with
poorer outcomes. Med4 also has significantly
reduced expression in breast cancer cells.
• However, the specific role that Med4 plays in
enforcing dormancy and the mechanisms of
metastasis upon Med4 deregulation remain to be
elucidated.

Methods

Results

• Lentiviruses are useful carriers of vectors
containing the shRNA sequence and allow for
efficient knockdown of genes in mammalian cells.
Lentiviruses can integrate their genome into the
host cell genomes, allowing for stable, long-lasting
expression of shRNA.

Fig 6: Fluorescence microscopy images. Crimson and GFP fluorescence was detected
within the cells.

Objective
I silenced Med4 in dormant breast cancer cells by
cloning microRNA-E-based (miR-E) short hairpin
Med4 (shMed4) into lentiviral vectors and
transducing the cells.
This approach allows for the investigation of the
mechanisms of metastatic reactivation and how
Med4 enforces dormancy.

Fig 7: Validating knockdown efficiency with Real-Time Quantitative Reverse
Transcription PCR (qRT-PCR). Decreased Med4 mRNA levels were seen for shMed4#1
and shMed4 #4 compared to NTC. shMed4 #1 and #4 had increased Acta2 and My19 (actin)
mRNA levels. Gapdh mRNA levels were similar for all samples. * = p-value < 0.05, ** = pvalue < 0.01, *** = p-value < 0.001.

Fig 8: Validating knockdown efficiency with
Western Blot Analysis. Decreased amounts of
Med4 protein were detected for shMed4 #1 and
#4 compared to NTC. shMed4 #1 and #4 had
increased protein levels for α-SMA (actin).
RhoGDI levels were similar for all samples.

Fig 3: Overview of Methods. DNA template containing shMed4 sequence was cloned into
the lentiviral vector, stable dormant breast cancer cell lines were generated with the lentiviral
vector incorporated into the genome, and knockdown efficiency was validated.
Fig 1: DNA Construct for Lentiviral Vector. SFFV and PGK are Pol-II promoters.
Crimson is a reporter protein for miR-E-based shMed4, which has XhoI and EcoRI
restriction sites, and Neomycin is a marker gene for antibiotic resistance.

Results

Methods
• Short hairpin RNA (shRNA)
is an engineered RNA
molecule that silences a
specific gene via RNA
interference.
• microRNA-adapted
shRNA have a
microRNA
(miRNA) backbone
Fig 2: miR-E shRNA. The guide strand that binds
incorporated into
to the target mRNA is highlighted in yellow.
Adapted from Fellmann et al.
the shRNA
molecule, allowing it to be expressed by Pol-II
promoters and processed by the endogenous
miRNA pathways. The processed shRNA then binds
to the target mRNA and induces mRNA degradation
or suppresses translation of that gene, silencing it.
• Utilizing this miRNA pathway leads to less toxicity,
more precise processing of shRNA, and the ability to
transcribe several shRNA’s/reporter genes under one
promoter, as compared to simple stem-loop shRNA.

Fig 4: Agarose gels to confirm successful PCR of DNA template and vector
purification. Left: Digested PCR product of DNA template on 2% agarose gel. The
digested product is at the expected size for all samples, a little over 100 bp. Right:
Digested and uncut vector containing DNA template on 1% agarose gel after maxiprep and
subsequent isolation in preparation for transformation into E. coli cells. The digested
vectors for both shMed4 #1 and shMed4 #4 are linear and around the expected size,
between 10 kb and 20 kb. As expected, the uncut vectors for shMed4 #1 and shMed4 #4
contain a nicked, circular vector and supercoiled vector, without any single-stranded,
circular vector present.

Conclusion
• Silencing of Med4 using this DNA construct was
successful based on the qRT-PCR and Western Blot
results.
• This knockdown method can allow for additional
studies that explore the interactions and signaling
pathways related to Med4 and metastatic
reactivation.
• Further investigation can include RNA-sequencing,
immunofluorescence staining, drug treatment, and
co-knockdown of genes.
• Understanding the mechanisms through which
depletion of Med4 promotes metastatic relapse may
lead to the identification of novel biomarkers and
therapies that may benefit a substantial fraction of
breast cancer patients.
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Fig 5: Fluorescence-activated cell sorting based on Crimson and Green Fluorescent
Protein (GFP) expression. Crimson signals for shMed4 expression and GFP is linked to
luciferase for in vivo imaging of metastasis. Cells with the highest Crimson and GFP signals
were sorted and tested for validation of shMed4 knockdown efficiency.
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